AAAAAA

   
Results: 1-7 |
Results: 7

Authors: Stopeck, AT Jones, A Hersh, EM Thompson, JA Finucane, DM Gutheil, JC Gonzalez, R
Citation: At. Stopeck et al., Phase II study of direct intralesional gene transfer of allovectin-7, an HLA-B7/beta 2-microglobulin DNA-liposome complex, in patients with metastatic melanoma, CLIN CANC R, 7(8), 2001, pp. 2285-2291

Authors: Tsang, TC Brailey, JL Vasanwala, FH Wu, RS Liu, F Clark, PR Meade-Tollin, L Luznick, L Stopeck, AT Akporiaye, ET Harris, DT
Citation: Tc. Tsang et al., Construction of new amplifier expression vectors for high levels of IL-2 gene expression, INT J MOL M, 5(3), 2000, pp. 295-300

Authors: Stopeck, AT Gessner, A Miller, TP Hersh, EM Johnson, CS Cui, HY Frutiger, Y Grogan, TM
Citation: At. Stopeck et al., Loss of B7.2 (CD86) and intracellular adhesion molecule 1 (CD54) expression is associated with decreased tumor-infiltrating T lymphocytes in diffuse B-cell large-cell lymphoma, CLIN CANC R, 6(10), 2000, pp. 3904-3909

Authors: Clark, PR Stopeck, AT Ferrari, M Parker, SE Hersh, EM
Citation: Pr. Clark et al., Studies of direct intratumoral gene transfer using cationic lipid-complexed plasmid DNA, CANC GENE T, 7(6), 2000, pp. 853-860

Authors: Clark, PR Stopeck, AT Parker, SE Hersh, EM
Citation: Pr. Clark et al., Cationic lipid gene transfer of an IL-2 transgene leads to activation of natural killer cells in a SCID mouse human tumor xenograft, CELL IMMUN, 204(2), 2000, pp. 96-104

Authors: Clark, PR Stopeck, AT Brailey, JL Wang, Q McArthur, J Finer, MH Hersh, EM
Citation: Pr. Clark et al., Polycations and cationic lipids enhance adenovirus transduction and transgene expression in tumor cells, CANC GENE T, 6(5), 1999, pp. 437-446

Authors: Galanis, E Hersh, EM Stopeck, AT Gonzalez, R Burch, P Spier, C Akporiaye, ET Rinehart, JJ Edmonson, J Sobol, RE Forscher, C Sondak, VK Lewis, BD Unger, EC O'Driscoll, M Selk, L Rubin, J
Citation: E. Galanis et al., Immunotherapy of advanced malignancy by direct gene transfer of an interleukin-2 DNA/DMRIE/DOPE lipid complex: Phase I/II experience, J CL ONCOL, 17(10), 1999, pp. 3313-3323
Risultati: 1-7 |